Institutional Sign In

Go

Sanofi-Aventis Czech Republic

Created with Highcharts 6.0.4Sales and Profits (CZK mil)SalesNet Profit2004200520062007200820092010201120122013201420152016201702.5k5k7.5k10k-250255075100

Sanofi-Aventis CR's Cash & Cash Equivalents fell 93.9% yoy to CZK 0.719 mil in 2017

By Helgi Library - April 2, 2020

Sanofi-Aventis Czech Republic's total assets reached CZK 3,210 mil at the end of 2017, up 12.1% compared to the previous year. ...

Sanofi-Aventis CR's Cash & Cash Equivalents fell 93.9% yoy to CZK 0.719 mil in 2017

By Helgi Library - April 2, 2020

Sanofi-Aventis Czech Republic's total assets reached CZK 3,210 mil at the end of 2017, up 12.1% compared to the previous year. ...

Profit Statement 2015 2016 2017
Sales CZK mil 6,596 6,700 7,268
Gross Profit CZK mil 693 538 1,684
EBITDA CZK mil 94.6 20.1 50.7
EBIT CZK mil 89.5 15.5 39.0
Financing Cost CZK mil 2.24 2.75 5.09
Pre-Tax Profit CZK mil 87.2 12.7 33.9
Net Profit CZK mil 58.6 37.0 15.2
Balance Sheet 2015 2016 2017
Total Assets CZK mil 2,635 2,864 3,210
Non-Current Assets CZK mil 34.3 31.6 132
Current Assets CZK mil 2,597 2,829 3,075
Working Capital CZK mil 1,420 1,626 1,745
Shareholders' Equity CZK mil 699 738 752
Liabilities CZK mil 1,937 2,126 2,458
Total Debt CZK mil 404 586 775
Net Debt CZK mil 404 574 774
Ratios 2015 2016 2017
ROE % 8.76 5.15 2.05
ROCE % 4.39 2.38 0.863
Gross Margin % 10.5 8.03 23.2
EBITDA Margin % 1.43 0.301 0.698
EBIT Margin % 1.36 0.231 0.536
Net Margin % 0.889 0.553 0.210
Net Debt/EBITDA 4.27 28.5 15.3
Net Debt/Equity % 57.8 77.8 103
Cost of Financing % 0.511 0.556 0.748
Cash Flow 2015 2016 2017
Total Cash From Operations CZK mil 70.6 -159 -90.1
Total Cash From Investing CZK mil -2.71 -1.99 -110
Total Cash From Financing CZK mil -67.1 182 189
Net Change In Cash CZK mil 0.726 20.9 -11.1
Cash Conversion Cycle days 79.3 89.6 89.5
Cash Earnings CZK mil 63.7 41.7 27.0
Free Cash Flow CZK mil 67.8 -161 -200

Get all company financials in excel:

Download Sample   $19.99